Medpace Holdings (NASDAQ: MEDP) reported Q2 EPS of $0.38, $0.08 better than the analyst estimate of $0.30. Revenue for the quarter came in at $94.6 million versus the consensus estimate of $92.71 million.

GUIDANCE:

Medpace Holdings sees FY2017 EPS of $1.36-$1.46, versus the consensus of $1.35. Medpace Holdings sees FY2017 revenue of $373-385 million, versus the consensus of $377.12 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.